Ignite Creation Date:
2025-12-24 @ 4:32 PM
Ignite Modification Date:
2026-02-01 @ 4:41 AM
Study NCT ID:
NCT02763566
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-11
First Post:
2016-05-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12-05
Start Date Type:
ACTUAL
Primary Completion Date:
2019-03-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-01
Completion Date Type:
ESTIMATED
First Submit Date:
2016-05-04
First Submit QC Date:
None
Study First Post Date:
2016-05-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-03-16
Results First Submit QC Date:
None
Results First Post Date:
2020-03-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-29
Last Update Post Date:
2025-09-11
Last Update Post Date Type:
ESTIMATED